Conclusions
MIS-C has overlapping clinical and laboratory features highlighting the added difficult challenge of diagnosing EVALI during the COVID-19 pandemic. We stress the importance of a through history and possible drug screening when COVID-19 testing is negative in concerning clinical presentations.